瓦尔酸单一治疗对甲状腺功能测试和症儿童水平的影响
Pinki Alhyan1, Anju Aggarwal2, Neelam Chhillar3
1Pediatrics, University College of Medical Sciences, Delhi, IND.
Cureus
|July 3, 2023
概括
在患有的儿童中,单独使用酸治疗显著改变了甲状腺功能测试和血清水平. 建议进行监测和潜在的补充.
科学领域:
- 儿科神经学 儿科神经学
- 内分泌学 在内分泌学.
- 临床化学 临床化学
背景情况:
- 众所周知,抗发作药物瓦尔酸盐会影响甲状腺功能.
- 在病发病过程中起作用,可能会影响酸的疗效和甲状腺状况.
研究的目的:
- 评估六个月的瓦尔酸单疗对患有的儿童甲状腺功能测试 (TFT) 和血清 (Mg) 水平的影响.
- 调查这些水平与临床人口统计因素之间的相关性.
主要方法:
- 患有新诊断的的儿童 (3-12岁) 接受了氨酸单疗法.
- 在基线和六个月后收集血清样本以分析TFT,Mg和酸水平.
- 用化学发光分析了甲状腺功能测试,并用色度测量.
主要成果:
- 六个月后,甲状腺刺激激素 (TSH) 的显著增加和自由甲状腺素 (FT4) 的显著减少被观察到.
- 血清含量显著降低.
- 血清氨酸水平与TFT或Mg之间没有发现显著的关联,年龄,性别或重复发作也没有影响.
结论:
- 六个月的氨酸单疗法改变了儿科患者的TFT和血清Mg水平.
- 建议对TFT和Mg进行常规监测,必要时考虑补充.
更多相关视频
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
350
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
350
Antiepileptic Drugs: Potassium Channel Activators
215
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
215
Antiepileptic Drugs: GABAergic Pathway Potentiators
467
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
467
Antiepileptic Drugs: Calcium Channel Blockers
468
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
468
Antiepileptic Drugs: Glutamate Antagonists
427
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
427
Electroconvulsive Therapy
75
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
75


